Recent studies in non-human model systems have shown therapeutic potential of nucleoside-modified messenger RNA (modRNA) treatments for lysosomal storage diseases. Here, we assessed the efficacy of a modRNA treatment to restore the expression of the galactosidase alpha (GLA), which codes for α-Galactosidase A (α-GAL) enzyme, in a human cardiac model generated from induced pluripotent stem cells (iPSCs) derived from two individuals with Fabry disease. Consistent with the clinical phenotype, cardiomyocytes from iPSCs derived from Fabry-affected individuals showed accumulation of the glycosphingolipid Globotriaosylceramide (GB3), which is an α-galactosidase substrate. Furthermore, the Fabry cardiomyocytes displayed significant upregulation of lysosomal-associated proteins. Upon GLA modRNA treatment, a subset of lysosomal proteins were partially restored to wild-type levels, implying the rescue of the molecular phenotype associated with the Fabry genotype. Importantly, a significant reduction of GB3 levels was observed in GLA modRNA-treated cardiomyocytes, demonstrating that α-GAL enzymatic activity was restored. Together, our results validate the utility of iPSC-derived cardiomyocytes from affected individuals as a model to study disease processes in Fabry disease and the therapeutic potential of GLA modRNA treatment to reduce GB3 accumulation in the heart.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502840 | PMC |
| http://dx.doi.org/10.1016/j.ajhg.2023.07.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inflammatory Pseudotumor of the Spleen in a Patient With Psoriatic Arthritis: A Diagnostic Challenge in the COVID-19 Era.
Cureus
November 2024
Department of Pathology (Laboratory of General Pathology & Pathological Anatomy), Aristotle University of Thessaloniki, Thessaloniki, GRC.
The baseline inflammatory microenvironment in various organs of patients, which is shaped by pre-existing conditions and circulating drugs at the time before viral antigen exposure, may affect the severity of coronavirus disease-19 (COVID-19) infection and the nature of its complications. Inflammatory pseudotumor (IPT) of the spleen may represent one such complication that merits further investigation. We describe the case of a patient, who was under long-term treatment with a tumor necrosis factor inhibitor (TNFi), for psoriatic arthritis (PsA) and developed an inflammatory mass in the spleen, accompanied by systemic manifestations.
View Article and Find Full Text PDFHepatocyte growth factor-modified adipose-derived mesenchymal stem cells inhibit human hypertrophic scar fibroblast activation.
J Cosmet Dermatol
December 2024
Medical College Wuhan University of Science and Technology, Wuhan, Hubei, China.
Purpose: Nucleoside-modified messenger RNA (modRNA) holds the potential for facilitating genetic enhancement of stem cells. In this study, modRNA encoding hepatocyte growth factor (modHGF) was used to chemically modify adipose-derived mesenchymal stem cells (ADSCs) and the effect of modified ADSCs on the activation of hypertrophic scar fibroblasts (HSFs) was evaluated.
Methods: CCK-8, wound healing, and transwell assays were utilized to evaluate the viability and migratory potential of modHGF-engineered ADSCs and their effect on HSF activation.
Modified mRNA-Mediated Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling.
Int J Mol Sci
June 2024
Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10019, USA.
Article Synopsis
- ModRNAs are showing promise as a delivery method for gene therapy, particularly highlighted by their success in COVID-19 vaccines, showcasing their safety and effectiveness.
- A study investigated the use of modRNA to express the CCN5 protein, which could prevent cardiac fibrosis and improve heart function in mice after a heart attack, while avoiding harmful side effects.
- Results indicated that administering CCN5 through modRNA led to reduced fibrosis and better heart function in both prevention and treatment scenarios, indicating its potential as a safe and efficient treatment for heart failure caused by myocardial infarction.
Potential Application of Modified mRNA in Cardiac Regeneration.
Cell Transplant
May 2024
Department of Plastic Surgery, Addenbrooke's Hospital, Cambridge, UK.
Heart failure remains the leading cause of human death worldwide. After a heart attack, the formation of scar tissue due to the massive death of cardiomyocytes leads to heart failure and sudden death in most cases. In addition, the regenerative ability of the adult heart is limited after injury, partly due to cell-cycle arrest in cardiomyocytes.
View Article and Find Full Text PDFROS-Responsive Injectable Hydrogel Loaded with SLC7A11-modRNA Inhibits Ferroptosis and Mitigates Intervertebral Disc Degeneration in Rats.
Adv Healthc Mater
October 2024
Department of Orthopedics, Huashan Hospital, Fudan University, Shanghai, 200040, P. R. China.
Intervertebral disc degeneration (IVDD) is the primary cause of low back pain, with oxidative stress being a recognized factor that causes its development. Presently, low back pain imposes a significant global economic burden. However, the effectiveness of treatments for IVDD remains extremely limited.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!